Recent Articles from GlobeNewswire

Fund to Begin Trading Under New Ticker “UFOX” on April 30, 2026

Fayetteville, Georgia, April 30, 2026 (GLOBE NEWSWIRE) -- Camp Southern Ground is proud to announce a special culinary partnership with Chef Hadi Rabai, owner of The BeiRut in Peachtree City, for its upcoming Farm + Table Homegrown Supper on May 21, 2026.

MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- Versus Systems Inc. (NASDAQ: VS), a leading provider of gamification and audience engagement technology, has renewed its technology partnership with the Texas Rangers, allowing the club to continue using the company’s Filter Fan Cam platform during home games through the 2026 Major League Baseball season (https://nnw.fm/TGmmv).

Ramat Gan, Israel, April 30, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment of cancer and inflammatory diseases, today announced  positive clinical data from its Phase 2a study of namodenoson in patients with advanced pancreatic cancer.

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

PHOENIX, April 30, 2026 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared under its dividend policy a monthly cash dividend in the amount of $0.02533 per common share (an annual dividend rate of $0.30396 per share).

, April 30, 2026 (GLOBE NEWSWIRE) --

TEL AVIV, Israel, April 30, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2025 Healthy Future Report, outlining performance against its sustainability targets, which are focused on the issues most relevant to its business, patients and the planet. Teva surpassed all 2025 targets associated with its sustainability-linked bonds—totaling approximately $7.5 billion across its 2021 and 2023 issuances. These commitments reflect progress in areas such as climate action, health equity and access to medicines, linking financial and sustainability performance.

Expanded platform now includes commercial real estate financing, working capital, business expansion financing, equipment financing, cash flow lending, syndications and more

Special offers help families celebrate Mom’s special day more affordably - no matter the distance

HOUSTON, April 30, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the presentation of preclinical data from its CYPS317 program for psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting taking place May 13-15, 2026, in Chicago, Illinois.

Commencement of activities in international markets is supported by the successful completion of the Limited Market Release, followed by the Recent Full Market Release in the U.S. 

Innovative product formats and growing global acceptance are fueling a powerful long-term growth trajectory

Major Milestone Advances Master-Planned Community Development in Southwest Florida

DENVER, April 30, 2026 (GLOBE NEWSWIRE) -- Forge Nano, Inc., a leading U.S. based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition (“ALD”) technology for artificial intelligence (“AI”)-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. (“Archimedes II”) (NASDAQ: ATII), today announced a technical semiconductor seminar hosted in Kuala Lumpur, Malaysia.

PLANTATION, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: AENT), a premier distributor, logistics provider, and omnichannel fulfillment partner to the entertainment and pop culture collectibles industry, supplying more than 340,000 unique SKUs across physical media, video games, toys, licensed merchandise, and exclusive collectibles to over 35,000 retail and e-commerce storefronts, will hold a conference call on Thursday, May 14, at 4:30 p.m. Eastern Time to discuss its results for the third quarter of fiscal year 2026 ended March 31, 2026. A press release detailing these results will be issued prior to the call.

Two operators, chosen for what this Company is becoming as it scales

Veteran finance executive brings 25 Years of global energy value chain leadership to Eos

The listing on one of the world’s largest global cryptocurrency exchanges expands market access and secondary liquidity for Enlivex’s primary digital treasury asset

DALLAS, April 30, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has received the “Small Business Innovator Award” at the inaugural Texas Innovation Conference, held on April 22-23, 2026 at the campus of Texas Christian University.

LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB: OTLC), a clinical-stage biotechnology company focused on oncology and AI-driven solutions, today provided an update on the continued advancement of its proprietary AI platform and robotics integration as it approaches initial commercial deployment.

SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics (Nasdaq: PLRX) today announced the dosing of the first participant in the FORTIFY Phase 1b open-label indication expansion clinical trial of PLN-101095 in combination with pembrolizumab, in patients with immune checkpoint inhibitor (ICI)-refractory advanced or metastatic solid tumors. PLN-101095 is an oral, small molecule, dual selective inhibitor of the integrins αvβ8 and αvβ1.

Limited-time offer helps travelers 30 and under enroll ahead of peak summer travel

MACAU, April 30, 2026 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today reported its unaudited financial results for the first quarter of 2026.

MACAU, April 30, 2026 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (Nasdaq: MLCO) (“Melco Resorts” or the “Company”), a developer, owner, and operator of integrated resort facilities in Asia and Europe, today reported its unaudited financial results for the first quarter of 2026.

Expanding Patent Portfolio Builds Competitive Moat Across Consumer Gaming, Enterprise, and Defense Markets

As super prime ranks grow, non-prime consumers face mounting debt pressures

Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 delivers advanced mineral protection with skincare benefits for daily defense

The iconic Coney Island-raised brand brings its legendary flavor into a modern, ingredient-forward era

A Nature-Inspired, Hospital-Grade Pump Designed to Mirror How a Baby Nurses, Featuring Dual Motors and Patent-Pending Flange Technology

RA'ANANA, Israel, April 30, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company") today announced the entry into a Joint Development Agreement (the “Agreement”) with Qarakal Quantum Ltd. ("Qarakal Quantum" or “Qarakal”), a full-stack quantum computing company developing superconducting quantum computers. The collaboration brings Inspira's Additively Manufactured Electronics (AME) platform, which operates under the brand name QTREX, into a working superconducting quantum environment to address one of the field's most persistent scaling challenges: high-performance signal connectivity in cryogenic environments.

BOCA RATON, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will present at the 21st Annual Needham Technology, Media & Consumer Conference being held May 12-14, 2026. Derek Dubner, Chief Executive Officer, and Dan MacLachlan, Chief Financial Officer, will virtually present and host investor meetings on May 14, 2026.

BairesDev also wins Bronze for AI-Driven Culture of Innovation, reflecting a shared belief that AI creates lasting value when it helps people work, learn, and deliver better.

DENVEVER, Colo., April 30, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGeneration,” “GrowGen” or “the Company”), one of the nation’s largest suppliers of specialty products for controlled environment agriculture (CEA), commercial cultivation, and retail garden centers, today announced that it will release its financial results for the first quarter ended March 31, 2026, on Tuesday, May 12, 2026, after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET.

TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland”) (TSX: NPI) today announced the signing of a long-term Corporate Power Purchase Agreement (“CPPA”) with Taiwan Semiconductor Manufacturing Company (“TSMC”) for additional power from its Hai Long offshore wind project in Taiwan (“Hai Long” or the “Project”).

NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- GPGI, Inc. (NYSE: GPGI), a diversified multi-industry platform for companies with great positions in good industries, today announced it will host a conference call on Thursday, May 7, 2026, at 8:00 a.m. Eastern Daylight Time (EDT) to discuss its financial results for the first quarter ended March 31, 2026. GPGI’s earnings results will be reported in a press release prior to the call.

NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Xcel Brands (NASDAQ:XELB), an industry leading media and consumer products company specializing in building influencer-led brands through social commerce and live streaming, announces the sale of luxury fine jewelry brand Judith Ripka.

Company showcases platform-wide advancements and introduces agentic commerce capabilities that enable merchants to sell, operate and grow in an AI-driven world

Industry leader equips families for safer summers with expert guidance and its Safer Summer Checklist

SANTIAGO, Chile, April 30, 2026 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its results1 for the three-month period ended March 31, 2026, and first quarter 2026 (1Q26).

Mosaic SoC is building next-generation perception chips that help devices see and understand their environment in real time at minimal power.

THE WOODLANDS, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its first quarter 2026 financial results on Thursday, May 7, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update. 

New capabilities empower organizations to map the unmappable, visualize cross-environment attack paths, and validate segmentation across IT, OT, and IoT

LONDON, April 30, 2026 (GLOBE NEWSWIRE) -- Diginex Limited (Nasdaq: DGNX) ("Diginex" or the "Company"), a provider of ESG, sustainability, and compliance solutions, today provided a corporate update outlining a significant strategic transformation following the proposed acquisition of Resulticks Global Companies Pte. Limited ("Resulticks") at an implied valuation of approximately US$1.5 billion in an all-share transaction.

- Company Will Discuss Data and Report First Quarter 2026 Financial Results on May 8 -

ATLANTA, April 30, 2026 (GLOBE NEWSWIRE) -- Lucasys Inc, a leading provider of cloud tax software for North American utilities and energy companies, today announced that multiple oil & gas companies have subscribed to the Lucasys Income Tax Suite. The new customers represent a significant expansion of Lucasys’ customer base beyond its core regulated utility market, marking a strategic milestone as the company extends its industry-leading tax platform into the broader energy sector.

New facility to strengthen regional distribution and meet growing demand for energy independence

Awarded Top 5 Industry Ranking, Underscored by Strong Growth and Market Share Gains

Q1 revenue equals more than 125% of audited FY2025 revenue, reinforcing confidence in Rezolve Ai’s $360 million 2026 guidance

Vancouver, BC, April 30, 2026 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to report that its partner company Terra Clean Energy Corp. (“Terra”) is preparing to commence a targeted drill program on the Fraser Lakes B Uranium Deposit following up on the very encouraging results reported in the winter 2025 program. Skyharbour optioned the Project to Terra and under the Option Agreement, assuming the full 75% interest is earned, Terra will fund exploration expenditures totaling CAD $10,500,000, as well as pay Skyharbour $11,100,000 in cash, of which $6,500,000 can be settled for shares in the capital of Terra over the earn-in period.

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the nomination of Lykke Hinsch Gylvin, MD, EMBA, Chief Medical Officer and Head of Global Medicine at Boehringer Ingelheim, to its Board of Directors.

TARRYTOWN, N.Y., April 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 fourth quarter and year-end earnings release on Wednesday, May 13, 2026 after the market close. The following morning, May 14, at 8:30 a.m. ET, the Company will host a conference call to discuss the results.

BOSTON, April 30, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that Robert Connelly, Chief Executive Officer, Christopher Haqq, MD, PhD, Executive Vice President, Head of Research and Development and Chief Medical Officer, Pete DeMuth, PhD, Chief Scientific Officer, and Preetam Shah, MBA, PhD, Chief Strategy and Financial Officer, will participate in the upcoming Bank of America Healthcare Conference, taking place May 12-14, 2026, in Las Vegas, NV.

-- Airline Recognized as Industry Leader for Travel and Tourism --

Management to host conference call and webcast at 4:30 pm ET on that day

GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Singapore’s Health Sciences Authority (HSA) has approved an expanded indication for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to include prevention of mpox disease in adults determined to be at high risk for mpox infection.

SINGAPORE, April 30, 2026 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a leading tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Q1 2026 Report finds sports leading with $10.1B in volume, and crypto serving as the primary onboarding gateway into a market projected to reach $240B by year-end

VANCOUVER, BRITISH COLUMBIA, April 30, 2026 (GLOBE NEWSWIRE) -- HI-VIEW RESOURCES INC. (“Hi-View” or the “Company”) (CSE: GXLD; OTCQB: GXLDF; FSE: B630) announces the Company’s common shares have commenced trading on the OTCQB Venture Market ("OTCQB") under the symbol “GXLDF”. The OTCQB listing intended to enhance visibility with U.S. investors and improve trading accessibility.

NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, and led by Professor Paolo A. Ascierto of the Istituto Nazionale Tumori Fondazione “G. Pascale”, a leading cancer centre in Europe

FRAUENFELD, Switzerland, April 30, 2026 (GLOBE NEWSWIRE) -- Aebi Schmidt Holding AG (NASDAQ: AEBI) (“Aebi Schmidt Group” or the “Company”), a world-class specialty vehicles leader, will announce its first quarter 2026 earnings before the market opens on Thursday, May 14, 2026, and host an earnings conference call and webcast at 8:30am Eastern Time the same day.

MINNEAPOLIS and TAMPA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo”), a multi-state cannabis operator, and FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a vertically-integrated, multi-state cannabis company, today announced that they have entered into a definitive arrangement agreement (the “Arrangement Agreement”) pursuant to which Vireo will acquire all of the issued and outstanding common shares of FLUENT (after conversion of all (i) proportionate voting shares of FLUENT and (ii) non-voting, non-participating exchangeable shares of FLUENT) (the “FLUENT Shares”) in exchange for Vireo Shares (as defined below) (the “Transaction”).

WASHINGTON, April 30, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today released financial results for the first quarter ended March 31, 2026.

Record Sales of $5.5 Billion Drive Record Cash Flow and Adjusted EPS; Orders +9%

NEW YORK and TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that Eric So, Helus Pharma’s Interim Chief Executive Officer, will be speaking at the 29th Annual Milken Institute Global Conference on a panel entitled “The Next Wave of Health Innovation.” The Conference will take place May 3-6, 2026, at The Beverly Hilton & Waldorf Astoria in Los Angeles, and the panel will be held on Monday, May 4, 2026, at 2:30 p.m. PDT.

GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio,” or the “Company”), today announced its financial results for the quarter ended March 31, 2026, and provided an overview of the Company’s corporate developments. Barinthus Bio is an immunology and inflammation (“I&I”) company focused on developing therapies that promote immune tolerance with curative potential.

PALO ALTO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that it will release its first quarter 2026 financial results and business update after the market closes on Thursday, May 7, 2026. BridgeBio will host a conference call to discuss the financial results and program updates at 4:30 pm ET the same day.

Capacity expected to scale to $50 million over three years; program anticipated to contribute approximately $6 million in revenue in Year 1, scaling alongside capacity

WAYNE, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or “the Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced that it will report its first quarter 2026 financial results before market open on Thursday, May 7, 2026. Palvella management will host a conference call for investors at 8:30 a.m. ET on that same day to discuss the results and provide a corporate update.

Shelton, CT, April 30, 2026 (GLOBE NEWSWIRE) --

BEIJING, April 30, 2026 (GLOBE NEWSWIRE) -- Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (“SEC”) on April 30, 2026. The annual report can be accessed on the Company’s investor relations website at ir.yb-inc.com.

Company Increases Full-Year 2026 Adjusted Earnings Per Share Guidance

JOHNS CREEK, Ga., April 30, 2026 (GLOBE NEWSWIRE) -- Saia, Inc. (Nasdaq: SAIA) today reported first quarter 2026 financial results. For both the first quarter of 2026 and 2025 diluted earnings per share were $1.86.

SAN DIEGO and TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF) announced today that closing of the previously announced arrangement (the “Arrangement”) with Hanmi Pharmaceutical Co. Ltd. (“Hanmi”) and HS North America Ltd., a wholly owned subsidiary of Hanmi (“Hanmi Purchaser” and together with Hanmi, the “Hanmi Purchasers”), has been delayed as certain Korean regulatory approvals pertaining to the Arrangement remain in progress. The parties do not anticipate that the review will prevent closing and continue to work toward completing the Arrangement that they now target for the month of May. The Company will provide a further update when available.